Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Isoflurane for Long-Term ICU Sedation
NCT01983800Phase 2Completed
- Sponsor
- University Health Network
- Start
- Jul 2013
- Primary completion
- Feb 2018
- Modality
- Allosteric Modulators
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of isoflurane in critical illness (2 arms), sponsored by University Health Network. Primary endpoints: Atmospheric Volatile Concentration, Sedation Quality and 3 more. Started Jul 2013; status: completed.
02
Drugs
isoflurane
03
Conditions
critical illness
Beyond the preview
Go deeper on NCT01983800.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01983800.